{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T08:40:01Z","timestamp":1744533601685,"version":"3.40.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.rceng.2024.11.009","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:18:50Z","timestamp":1738959530000},"page":"184-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A prediction model for complications caused by portal hypertension or liver cancer in a Spanish cohort of chronic hepatitis B patients"],"prefix":"10.1016","volume":"225","author":[{"given":"P.","family":"Gavil\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Gavil\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Clavijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Viciana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-A.","family":"Gonzalez-Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2021","series-title":"Hepatitis B fact sheet","key":"10.1016\/j.rceng.2024.11.009_bib0005"},{"key":"10.1016\/j.rceng.2024.11.009_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.rceng.2024.11.009_bib0015","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/liv.13142","article-title":"Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis","volume":"36","author":"Raffetti","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.rceng.2024.11.009_bib0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.rceng.2024.11.009_bib0025","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/ cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"53","author":"Chan","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.rceng.2024.11.009_bib0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.rceng.2024.11.009_bib0035","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.rceng.2024.11.009_bib0040","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.rceng.2024.11.009_bib0045","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.rceng.2024.11.009_bib0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.rceng.2024.11.009_bib0055","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.rceng.2024.11.009_bib0060","first-page":"624A","article-title":"PALBI-an objective score based on platelets, albumin bilirubin stratifies HCC patients undergoing resection & ablation better than child\u2019s classification","volume":"62","author":"Roayaie","year":"2015","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.rceng.2024.11.009_bib0065","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.dld.2019.01.011","article-title":"Albumin-Bilirrubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis","volume":"51","author":"Wang","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.rceng.2024.11.009_bib0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/jvh.12638","article-title":"Usefulness of albumin-bilirrubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis","volume":"24","author":"Chen","year":"2017","journal-title":"J Viral Hepat"},{"issue":"8","key":"10.1016\/j.rceng.2024.11.009_bib0075","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cgh.2007.06.015","article-title":"Risk and predictors of mortality associated with chronic hepatitis B infection","volume":"5","author":"Iloeje","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.rceng.2024.11.009_bib0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/apt.15803","article-title":"Mortality in adults with chronic hepatitis B infection in the United States: a population-based study","volume":"52","author":"Zhou","year":"2020","journal-title":"Aliment PharmacolTher"},{"key":"10.1016\/j.rceng.2024.11.009_bib0085","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/cid\/ciy598","article-title":"Mortality among patients with chronic hepatitis B infection: the chronic hepatitis Cohort Study (CHeCS)","volume":"68","author":"Bixter","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rceng.2024.11.009_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1200\/JCO.2007.13.2043","article-title":"High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma","volume":"26","author":"Chan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rceng.2024.11.009_bib0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.rceng.2024.11.009_bib0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1440-1746.2007.04857.x","article-title":"Long-term outcome of chronic hepatitis B based on histological grade and stage","volume":"22","author":"Park","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.rceng.2024.11.009_bib0105","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1038\/sj.onc.1209557","article-title":"Southern Europe as an example of interaction between environmental factors: a systematic review of the epidemiologic evidence","volume":"25","author":"Donato","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.rceng.2024.11.009_bib0110","doi-asserted-by":"crossref","first-page":"S 35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rceng.2024.11.009_bib0115","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00042737-200012060-00019","article-title":"Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study","volume":"12","author":"Huo","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.rceng.2024.11.009_bib0120","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1111\/j.1572-0241.2002.07057.x","article-title":"Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients","volume":"97","author":"Fattovich","year":"2002","journal-title":"Am J Gastroeneterol"},{"key":"10.1016\/j.rceng.2024.11.009_bib0125","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/bjc.1997.493","article-title":"Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study","volume":"76","author":"Tsai","year":"1997","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.rceng.2024.11.009_bib0130","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.3390\/v14112579","article-title":"Impact of hepatitis B virus infection, non-alcoholic fatty liver disease and hepatitis C Co-infection on liver-related death among people tested for hepatitis B virus in British Columbia: results from a large longitudinal population-based cohort study","volume":"14","author":"Makuza","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.rceng.2024.11.009_bib0135","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41598-023-28351-3","article-title":"Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection","volume":"13","author":"Lv","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.rceng.2024.11.009_bib0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1478-3231.2007.01482.x","article-title":"Impact of non-alcolic fatty liver disease on chronic hepatitis B","volume":"27","author":"Bondini","year":"2007","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.rceng.2024.11.009_bib0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12881-020-01026-w","article-title":"Association between IL28 B polymorphisms and outcomes of hepatitis B virus infection: a meta-analysis","volume":"21","author":"Zhao","year":"2020","journal-title":"BMC Med Genetics"},{"issue":"4","key":"10.1016\/j.rceng.2024.11.009_bib0150","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.rceng.2024.11.009_bib0155","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.rceng.2024.11.009_bib0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jhep.2008.07.023","article-title":"Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B","volume":"50","author":"Yuen","year":"2009","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.rceng.2024.11.009_bib0165","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.2009.26.2675","article-title":"Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers","volume":"28","author":"Wong","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887425000153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887425000153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T08:14:32Z","timestamp":1744532072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2254887425000153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2254887425000153"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2024.11.009","relation":{},"ISSN":["2254-8874"],"issn-type":[{"type":"print","value":"2254-8874"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prediction model for complications caused by portal hypertension or liver cancer in a Spanish cohort of chronic hepatitis B patients","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2024.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2024.11.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}